EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Machine learning-powered, high-affinity modification strategies for aptamers

Gubu Amu, Xin Yang, Hang Luo, Sifan Yu, Huarui Zhang, Yuan Tian, Yuanyuan Yu, Shijian Ding, Yufei Pan, Zefeng Chen, Yixin He, Yuan Ma und 2 weitere

Acta Materia Medica · 2025 · 4 (1)

DOI: 10.15212/amm-2024-0065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Materia Medica, 2025. Verfasst von Gubu Amu und 13 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The binding affinity of aptamers to targets has a crucial role in the pharmaceutical and biosensing effects. Despite diverse post-systematic evolution of ligands by exponential enrichment (post-SELEX) modifications explored in aptamer optimization, accurate prediction of high-affinity modification strategies remains challenging. Sclerostin, which antagonizes the Wnt signaling pathway, negatively regulates bone formation. Our screened sclerostin aptamer was previously shown to exert bone anabolic potential. In the current study, an interactive methodology involving the exchange of mutual information between experimental endeavors and machine learning was initially proposed to design a high-affinity post-SELEX modification strategy for aptamers. After four rounds of interactive training (a total of 422 modified aptamer-target affinity datasets with diverse modification types and sites), an antifcial intelligence model with high predictive accuracy with a correlation coefficient of 0.82 between the predicted and actual binding affinities was obtained. Notably, the machine learning-powered modified aptamer selected from this work exhibited 105-fold higher affinity (picomole level K D value) and a 3.2-folds greater Wnt-signal re-activation effect compared to naturally unmodified aptamers. This approach harnessed the power of machine learning to predict the most promising high-affinity modification strategy for aptamers.

Zitieren

APA

Amu, G., Yang, X., Luo, H., Yu, S., Zhang, H., Tian, Y., Yu, Y., Ding, S., Pan, Y., Chen, Z., He, Y., Ma, Y., Zhang, B., & Zhang, G. (2025). Machine learning-powered, high-affinity modification strategies for aptamers. Acta Materia Medica, 4(1). https://doi.org/10.15212/amm-2024-0065

Vancouver

Amu G, Yang X, Luo H, Yu S, Zhang H, Tian Y, et al. Machine learning-powered, high-affinity modification strategies for aptamers. Acta Materia Medica. 2025;4(1). doi:10.15212/amm-2024-0065

BibTeX
@article{Amu2025,
  author = {Amu, Gubu and Yang, Xin and Luo, Hang and Yu, Sifan and Zhang, Huarui and Tian, Yuan and Yu, Yuanyuan and Ding, Shijian and Pan, Yufei and Chen, Zefeng and He, Yixin and Ma, Yuan and Zhang, Baoting and Zhang, Ge},
  title = {Machine learning-powered, high-affinity modification strategies for aptamers},
  journal = {Acta Materia Medica},
  year = {2025},
  volume = {4},
  number = {1},
  doi = {10.15212/amm-2024-0065}
}
Kostenlos starten →